Страна: Малайзія
мова: англійська
Джерело: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
NIFEDIPINE
PAHANG PHARMACY SDN. BHD.
NIFEDIPINE
30Tablet Tablets; 90 Tablet Tablets
KRKA
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_ CORDIPIN RETARD TABLET Nifedipine (20 mg) _ _ 1 WHAT IS IN THIS LEAFLET 1. What Cordipin retard is used for 2. How Cordipin retard works 3. Before you use Cordipin retard 4. How to use Cordipin retard 5. While you are using it 6. Side effects 7. Storage and Disposal of Cordipin retard 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of revision WHAT _CORDIPIN RETARD_ IS USED FOR The drug is intended for treatment of all kinds of high blood pressure and all kinds of angina pectoris (chest pain), particularly vasospastic and chronic stable one. HOW _CORDIPIN RETARD_ WORKS Nifedipine inhibits the influx of calcium into the cells of the heart muscle and the muscle cells in the walls of arteries. It decreases the consumption of oxygen directly by reducing heart work. The oxygen demand is also indirectly decreased as the heart is relieved. Cordipin retard tablet is a prolong- release tablet. The release of nifedipine is slower so nifedipine achieves the maximum concentrations in 2 to 4 hours and its effect persists for 10 to 12 hours. BEFORE YOU USE _CORDIPIN RETARD_ - _When you must not use it _ if you are allergic (hypersensitive) to nifedipine or any of the other ingredients of Cordipin retard; if you have ever had an allergic reaction to similar drugs (dihydropyridines); if you have impaired aortic valve (aortic stenosis); if you have a disorder of porphyrin metabolism (a type of metabolic disorder called porphyria); if you are pregnant or are breast- feeding. Patients with insufficient blood perfusion of organs, poor oxygen supply and too low blood pressure (cardiogenic shock) must not take the medicine. _ _ - _Before you start use it _ Contact your doctor immediately: if you feel pain or tightness in your chest after the first dose of Cordipin retard; if during treatment with Cordipin retard you suddenly experience more frequent, stronger and longer attacks of chest pain both at rest and during physical ac Прочитайте повний документ
Information for patients 1 CORDIPIN ® RETARD PROLONGED RELEASE TABLETS 20 MG NIFEDIPINE COMPOSITION 1 prolonged release tablet contains 20 mg nifedipine. ACTION Nifedipine inhibits the influx of calcium into the myocardial cells and the smooth muscle cells of arteries. It decreases the consumption of oxygen directly by reducing heart work. The oxygen demand is also indirectly decreased as the heart is relieved. The release of nifedipine from prolonged release tablets is slower so nifedipine achieves the maximum concentrations in 2 to 4 hours and its effect persists for 10 to 12 hours. INDICATIONS The drug is intended for treatment of all kinds of high blood pressure and all kinds of angina pectoris, particularly vasospastic and chronic stable one. CONTRAINDICATIONS The drug should not be used by patients hypersensitive to nifedipine or any of the other ingredients of the drug, by patients with cardiogenic shock, advanced aortic stenosis, porphyria and by nursing mothers. PRECAUTIONS Especially at the beginning of treatment and if certain groups intended for treatment of high blood pressure (beta blockers) are taken concomitantly, blood pressure may fall substantially, which some patients tolerate poorly. In patients taking beta blockers, heart failure may occur after the introduction of nifedipine therapy. The doctor will make more frequent appointments for control examinations, which you should pass regularly, even if you feel well. If you suffer from severe heart diseases (hypertrophic cardiomyopathy, unstable angina pectoris), diabetes, severe hepatic dysfunction or severe pulmonary hypertension and you are an elderly person, you will be closely monitored by your doctor during the introduction of nifedipine therapy. In patients with severe coronary disease, more frequent attacks of angina pectoris may occur at the beginning of treatment. Mild to moderate peripheral edema, typically associated with arterial vasodilation and not due to left ventricular dysfunction, occurs in about one in ten patients treated wi Прочитайте повний документ